日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

MetaMask for thermal-humidity regulation in cold-environment facial protection

MetaMask 是一款用于寒冷环境下面部防护的热湿调节面罩

Wang, Qifei; Yang, Yufeng; Liang, Qian; Yu, Jihong

TidyMass2: advancing LC-MS untargeted metabolomics through metabolite origin inference and metabolic feature-based functional module analysis

TidyMass2:通过代谢物来源推断和基于代谢特征的功能模块分析推进LC-MS非靶向代谢组学

Wang, Xiao; Liu, Yijiang; Jiang, Chao; Huang, Zinuo; Yan, Hong; Wong, Sunny H; Johnson, Caroline H; Zhang, Jingxiang; Ge, Yifei; Zhang, Feifan; Zhang, Junli; Lai, Renfu; Gao, Peng; Zhang, Xuebin; Shen, Xiaotao

GCN5 drives MASLD progression through LXRα/SREBP1c signaling pathway-mediated de novo lipogenesis.

GCN5 通过 LXRα/SREBP1c 信号通路介导的从头脂肪生成驱动 MASLD 进展。

Xiao Hai-Tao, Song Peng, Jin Jing, Wang Yong-Dan, Xu Yin-Yue, Wu He, Shao Xue-Xue, Gan Qi-Feng, He Jian, Wen Yan-Rong, Zhu Jing, Chen Bao-Yi, Zhou Ping, Lai Li-Na, Yang Hua, Li Ping, Zheng Zu-Guo

OCTN2 Activates a Non-Canonical Carnitine Metabolic Pathway to Promote MASH-HCC Progression and Immunotherapy Resistance.

OCTN2 激活非经典肉碱代谢途径,促进 MASH-HCC 进展和免疫治疗耐药性。

Xia Chuqi, Zhang Xiao, Li Jinze, Xu Ning, Hu Sheng, Lu Qiyu, Li Yuxuan, Xiao Taifu, Li Xu, Wang Xue, Xu Kequan, Liang Daoming

Lactylation-Driven YTHDC1 Alleviates MASLD by Suppressing PTPN22-Mediated Dephosphorylation of NLRP3.

乳酸驱动的 YTHDC1 通过抑制 PTPN22 介导的 NLRP3 去磷酸化来缓解 MASLD。

Zhang Feng, Zeng Linghua, Zou Kunkun, Lin Keying, Yao Fangting, Song Jinglun, Zhang Shumeng, Feng Hanshu, Yang Zhichao, Wang Chunlei, Diao Hongtao, Kong Xue, Pan Tengfei, Kim Joonki, Duo Tianqi, Li Linqiang, Bian Yu

Hepatic glutathione depletion ameliorates MASLD through selective protein oxidation and inhibition of lipogenesis.

肝脏谷胱甘肽耗竭可通过选择性蛋白质氧化和抑制脂肪生成来改善 MASLD。

Liu Xiang-Yu, Wang Guoxiao, Yu Yingying, Xiao Haopeng, Oh-Hashi Kentaro, Shi Xu, Zheng Shuning, Gerszten Robert, Kahn C Ronald

MassBank: an open and FAIR mass spectral data resource

MassBank:一个开放且符合 FAIR 原则的质谱数据资源

Neumann, Steffen; Meier, René; Wenk, Michael; Elapavalore, Anjana; Nishioka, Takaaki; Schulze, Tobias; Stravs, Michael; Tsugawa, Hiroshi; Matsuda, Fumio; Schymanski, Emma L

Supplementation of L-aspartate corrects MASLD and MASH in mice by inhibiting platelet-hepatocyte interaction-mediated mitochondrial fragmentation via the ATP-P2X7-NEK7-DRP1 axis.

补充 L-天冬氨酸可通过抑制血小板-肝细胞相互作用介导的线粒体断裂(通过 ATP-P2X7-NEK7-DRP1 轴)来纠正小鼠的 MASLD 和 MASH。

Cao Wen-Jie, Su Rui, Fu Hui-Ling, Wu Jun-Jie, Huang Lin-Sheng, Liu Fei-Fei, Liu Jin, Jiang Zhong-Ping, Xu Cong-Jun, Rao Yong, Huang Ling

TANK-binding kinase 1 protects against MASH progression via mitochondrial quality control.

TANK结合激酶1通过线粒体质量控制来防止MASH进展。

An Sung-Min, Jang Jun Hee, Sung Jin Hyun, Myung Ji Won, Jeon Yong Geun, Lee Won Taek, Jeon Jin Won, Yim Kyung Min, Lee Jae-Ho, Zhang Bichen, Seo Jong Bae, Im Seung Soon, Kim Jae Bum, Saltiel Alan R, Huh Jin Young

Posttranscriptional reprogramming controls MASLD progression through chronic ER stress adaptation.

转录后重编程通过慢性内质网应激适应来控制MASLD的进展。

Belloc Eulalia, Calderone Vittorio, Naranjo-Suarez Salvador, Mateo Lidia, Martin Judit, Malizia Florencia, Sibilio Annarita, Chanes Veronica, Ramirez-Pedraza Marta, Delgado M Eugenia, Drebber Uta, Rheinwalt Karl-Peter, Klein Sabine, Brol Maximilian Joseph, Schierwagen Robert, Trebicka Jonel, Aloy Patrick, Fernandez Mercedes, Mendez Raul